ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fieguth, H. G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Fieguth, H. G.
Related Collections
Right arrow Electrophysiology - arrhythmias

Ann Thorac Surg 2004;77:2094-2095
© 2004 The Society of Thoracic Surgeons

Invited commentary

Hans Gerd Fieguth, MD

Department of Cardiothoracic Surgery, Klinikum der Johan Wolfgang Goethe, Universitat, 60 590 Frankfurt am Main, Germany

e-mail: fieguth@em.uni-frankfurt.de

The first 20% of the full text of this article appears below.

Using a prospective randomized clinical trial, the authors of this paper evaluate the treatment of atrial fibrillation (AF) by pulmonary vein isolation in patients undergoing mitral valve surgery.

This patient population differs significantly from that with "lone" atrial fibrillation, since the left-sided origin of AF is well documented in patients with mitral valve disease. Several studies have been able to identify trigger substrates in the pulmonary . . . [Full Text of this Article]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.